# US 2022/0031949 A1 · Adjusting insulin delivery rates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031949 A1
- Document ID: US20220031949A1
- Status: Published application
- Kind: A1
- Application number: 17/451,128
- Filed: 2021-10-15
- Published: 2022-02-03
- Earliest claimed: 2016-01-14
- Assignees: Bigfood Biomedical, Inc.
- Applicants: Bigfood Biomedical, Inc.
- Inventors: Bryan Mazlish; Lane Desborough
- Web page: https://patentgrep.com/patent/US20220031949A1

## CPC

- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/4839: {combined with drug delivery}
- A61M 5/142: Pressure infusion, e.g. using pumps
- A61M 5/14244: {adapted to be carried by the patient, e.g. portable on the body}
- A61M 5/14248: {of the skin patch type}
- A61M 5/145: using pressurised reservoirs, e.g. by means of pistons
- G16H 20/17: delivered via infusion or injection
- G16H 40/60: for the operation of medical equipment or devices
- G16H 40/67: for remote operation
- A61B 2562/0295: Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
- A61M 2005/14208: {with a programmable infusion control system, characterised by the infusion program}
- A61M 2205/3303: Using a biosensor
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3561: local, e.g. within room or hospital
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2205/3584: using modem, internet or Bluetooth®
- A61M 2205/502: User interfaces, e.g. screens or keyboards
- A61M 2205/52: with memories providing a history of measured variating parameters of apparatus or patient
- A61M 2230/005: Parameter used as control input for the apparatus
- A61M 2230/201: Glucose concentration
- G16H 10/60: for patient-specific data, e.g. for electronic patient records
- G16H 40/40: for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
- G16H 50/30: for calculating health indices; for individual health risk assessment
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A method may include generating a first plurality of insulin delivery profiles that include a first series of insulin delivery actions spanning a first time interval, projecting a first plurality of future blood glucose values for each profile of the first plurality of profiles using up-to-date blood glucose levels, selecting one of the first plurality of profiles based upon comparing future blood glucose values for each profile and target blood glucose levels, delivering insulin for a second time interval that corresponds to a first action of the first profile, generating a second plurality of insulin delivery profiles for a third time interval, projecting a second plurality of future blood glucose values for each profile of the second plurality of profiles for the third time interval, and delivering a second dose of insulin for a fourth time interval shorter than the third time interval.

## Claims

### Claim 1

A method of providing insulin delivery instructions for an insulin delivery device, the method comprising:
selecting a first user-specific basal delivery profile permutation from a plurality of user-specific basal delivery profile permutations, the first user-specific basal delivery profile permutation having an intended basal rate and an intended delivery time duration for the intended basal rate;
generating insulin delivery instructions comprising the intended basal rate of the first user-specific basal delivery profile permutation and a first variable delivery time duration relative to the intended delivery time duration of the first user-specific basal delivery profile permutation; and
providing the generated insulin delivery instructions to the insulin delivery device.

### Claim 2 (depends on 1)

The method of claim 1, further comprising:
receiving blood glucose level data related to a user during the first variable delivery time duration;
estimating a future blood glucose level of the user based at least partially on the received blood glucose level data;
based at least partially on the estimated future blood glucose level, selecting a second user-specific basal delivery profile permutation from the plurality of user-specific basal delivery profile permutations;
generating updated insulin delivery instructions comprising the intended basal rate of the second user-specific basal delivery profile permutation and a second variable time duration relative to the intended delivery time duration of the second user-specific basal delivery profile permutation; and
providing the generated updated insulin delivery instructions to the insulin delivery device.

### Claim 3 (depends on 1)

The method of claim 1, further comprising:
receiving blood glucose level data related to a user during the first variable delivery time duration;
estimating a future blood glucose level of the user based at least partially on the received blood glucose level data;
based at least partially on the estimated future blood glucose level, generating updated insulin delivery instructions to continue to deliver medication according to the intended basal rate of the first user-specific basal delivery profile permutation for a second variable time duration relative to the intended delivery time duration of the second user-specific basal delivery profile permutation; and
providing the generated updated insulin delivery instructions to the insulin delivery device.

### Claim 4 (depends on 3)

The method of claim 3, wherein the first variable delivery time duration and the second variable time duration together are substantially equal to the intended delivery time duration of the first user-specific basal delivery profile permutation.

### Claim 5 (depends on 1)

The method of claim 1, wherein the first variable delivery time duration is less than the intended delivery time duration of the first user-specific basal delivery profile permutation.

### Claim 6 (depends on 1)

The method of claim 1, wherein the first variable delivery time duration is less than the intended delivery time duration of the first user-specific basal delivery profile permutation by one or more hours or by less than sixty minutes.

### Claim 7 (depends on 1)

The method of claim 1, further comprising:
responsive to a lack of up-to-date blood glucose data and a passage of the first variable delivery time duration, generating adjusted insulin delivery instructions comprising an adjusted basal rate; and
providing the adjusted insulin delivery instructions to the insulin delivery device.

### Claim 8 (depends on 7)

The method of claim 7, wherein the adjusted insulin delivery instructions comprise a generic basal rate.

### Claim 9 (depends on 1)

The method of claim 1, further comprising:
receiving one or more user-specific dosage parameters; and
generating the plurality of user specific basal delivery profile permutations based at least partially on the received one or more user-specific dosage parameters.

### Claim 10 (depends on 9)

The method of claim 9, wherein receiving one or more user-specific dosage parameters comprises receiving the one or more user-specific dosage parameters at a device remote to the insulin delivery device.

### Claim 11 (depends on 9)

The method of claim 9, wherein receiving one or more user-specific dosage parameters comprises receiving the one or more user-specific dosage parameters via wireless communication.

### Claim 12 (depends on 1)

The method of claim 1, wherein each of the plurality of user-specific basal delivery profile permutations comprises a projected effect of a respective basal delivery profile on a blood glucose level of a user.

### Claim 13

A system comprising:
a blood glucose monitor;
an insulin delivery device;
a controller remote from the blood glucose monitor and the insulin delivery device, the controller configured to:
select a first user-specific basal delivery profile permutation from a plurality of user-specific basal delivery profile permutations, the first user-specific basal delivery profile permutation having an intended basal rate and an intended delivery time duration for the intended basal rate;
generate insulin delivery instructions comprising the intended basal rate of the first user-specific basal delivery profile permutation and a first variable delivery time duration relative to the intended delivery time duration of the first user-specific basal delivery profile permutation;
transmit the generated insulin delivery instructions to the insulin delivery device
receive blood glucose level data related to a user during the first variable delivery time duration from the blood glucose monitor;
estimate a future blood glucose level of the user based at least partially on the received blood glucose level data;
based at least partially on the estimated future blood glucose level, determine whether a change to the intended basal rate or a time duration for which the intended basal rate is currently instructed to be delivered is warranted;
responsive to a determination that a change to the intended basal rate or the time duration for which the intended basal rate is currently instructed to be delivered is warranted, select a new user-specific basal delivery profile permutation from the plurality of user-specific basal delivery profile permutations, the new user-specific basal delivery profile permutation having a new intended basal rate and a new intended delivery time duration for the new intended basal rate; and
generate new insulin delivery instructions comprising the new intended basal rate of the new user-specific basal delivery profile permutation and a second variable delivery time duration relative to the new intended delivery time duration of the new user-specific basal delivery profile permutation.

### Claim 14 (depends on 13)

The system of claim 13, wherein the controller is further configured to repeatedly receive blood glucose level data related to the user, estimate future blood glucose levels of the user, determine whether changes are warranted, and select additional new user-specific basal delivery profile permutations.

### Claim 15 (depends on 13)

The system of claim 13, wherein the first variable delivery time duration is less than the intended delivery time duration of the first user-specific basal delivery profile permutation.

### Claim 16 (depends on 15)

The system of claim 15, wherein the second variable delivery time duration is less than the new intended delivery time duration of the first user-specific basal delivery profile permutation.

### Claim 17 (depends on 13)

The system of claim 13, wherein the first variable delivery time duration is less than the intended delivery time duration of the first user-specific basal delivery profile permutation by one or more hours or by less than sixty minutes.

### Claim 18 (depends on 17)

The system of claim 17, wherein the second variable delivery time duration is less than the new intended delivery time duration of the first user-specific basal delivery profile permutation by one or more hours or by less than sixty minutes.

### Claim 19 (depends on 13)

The system of claim 13, wherein the controller further configured to:
responsive to a lack of up-to-date blood glucose data from the blood glucose monitor and a passage of the second variable delivery time duration, generate adjusted insulin delivery instructions comprising an adjusted basal rate; and
transmit the adjusted insulin delivery instructions to the insulin delivery device.

### Claim 20

A method of providing insulin delivery instructions for an insulin delivery device, the method comprising:
responsive to received blood glucose data, selecting a first user-specific basal delivery profile permutation, the first user-specific basal delivery profile permutation having a first intended basal rate and a first intended delivery time duration for the first intended basal rate;
providing insulin delivery instructions to the insulin delivery device, the insulin delivery instructions comprising the first intended basal rate and a first variable delivery time duration relative to the first intended delivery time duration of the first user-specific basal delivery profile permutation;
responsive to received updated blood glucose data, selecting a second user-specific basal delivery profile permutation, the second user-specific basal delivery profile permutation having an second intended basal rate and a second intended delivery time duration for the second intended basal rate; and
providing updated insulin delivery instructions to the insulin delivery device, the updated insulin delivery instructions comprising the second intended basal rate and a second variable delivery time duration relative to the second intended delivery time duration of the second user-specific basal delivery profile permutation.
